Wednesday, September 09, 2020 1:55:46 PM
- No news, no pumping, likely indicates this is not a pump-n-dump and the professional, highly-connected leadership team is working through the FDA, political and big pharma landscapes.
- Hiring of a CMO and expanding trials into Europe indicates confidence in progress being made in the US and thus they are spending money to expand
- Preparing and publishing financials, website, pre-prints, partnerships, etc indicate a go-forward posture.
If these guys have a good product that will be approved by the FDA, they will become inundated with orders worldwide... its a massive effort behind the scenes that takes a while to come together. They already know what the results are, and if it were me running the show, I would not be pushing the FDA to hurry and approve, because we would not yet be in position to fulfill the need. Give these pros some time to pull the whole solution together; otherwise it could become a disaster with worldwide demand.
Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM